BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20572104)

  • 1. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
    Wald NJ
    Prenat Diagn; 2010 Jul; 30(7):619-21. PubMed ID: 20572104
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple of the median and its uses in antenatal screening].
    Jiangsu Province Birth Planning Commitee
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 7. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 9. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM; Dupuis HM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-1-fetoprotein in the amniotic fluid and blood of pregnant women].
    Zizkovský V; Koubová J; Havranová M; Chudý D; Fuchs V
    Cesk Gynekol; 1988 Jun; 53(5):330-9. PubMed ID: 2457452
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal screening tests facilitate risk assessment.
    Miller SM; Isabel JM
    MLO Med Lab Obs; 2002 Feb; 34(2):8-11, 14-6, 19; quiz 20-1. PubMed ID: 11881274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO; Stamilio DM; Nelson DB; Sehdev HM; Macones GA
    Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal screening for fetal neural-tube defects by immunodiffusion autoradiography (author's transl)].
    Zheng ZQ
    Zhonghua Fu Chan Ke Za Zhi; 1981 Oct; 16(4):209-10. PubMed ID: 6177478
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-fetoprotein. ACOG Technical Bulletin number 154--April 1991.
    Int J Gynaecol Obstet; 1992 Jul; 38(3):241-7. PubMed ID: 1280604
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for open neural tube defects from 21 to 25 weeks' gestation: the Manitoba experience.
    Björklund NK; MacDonald KM; Evans JA; Schneider CE; Chodirker BN
    Prenat Diagn; 2005 Aug; 25(8):715-7. PubMed ID: 16052469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Open neural tube defects in prenatal diagnosis].
    Zaremba J; Roszkowski T; Szirkowiec W
    Przegl Lek; 1998; 55(4):159-63. PubMed ID: 9656739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of maternal serum alpha-fetoprotein testing.
    Dyson RD
    Am Fam Physician; 1996 Nov; 54(6):1890, 1893. PubMed ID: 8900347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.